{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2934103", "DateCompleted": {"Year": "1986", "Month": "02", "Day": "13"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["rus"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0365-9615", "JournalIssue": {"Volume": "100", "Issue": "12", "PubDate": {"Year": "1985", "Month": "Dec"}}, "Title": "Biulleten' eksperimental'noi biologii i meditsiny", "ISOAbbreviation": "Biull Eksp Biol Med"}, "ArticleTitle": "[Immunomodulating and antitumor activity of polysaccharides of plant origin].", "Pagination": {"StartPage": "741", "EndPage": "743", "MedlinePgn": "741-3"}, "Abstract": {"AbstractText": ["The effect of the polysaccharides tagetan, palustran, and zymosan injections to BALB/c mice on the formation of cytotoxic T-lymphocytes in allogenic mixed culture has been studied. Lymphocytes from a 5-day-old mixed culture were characterized by the greatest cytotoxic activity, with spleenocytes serving as reacting cells in mice injected 12-50 mg/kg of tagetan, 20 mg/kg of zymosan and 10-100 mg/kg of palustran, 7, 3 and 5 days, respectively, before the beginning of allogeneic stimulation in vitro. To determine correlation between immunostimulating and antitumor activity 25 mg/kg of tagetan every 14 days, 20 mg/kg of zymosan every 6 days, and 10 mg/kg of palustran every 6 days, were injected to BALB/c and BALB/c nu/nu mice prior to and following subcutaneous implantation of Crocker sarcoma cells. By the end of the first month of immunotherapy the tumour size in mice on tagetan or zymosan was 2-2,5 times smaller than in control animals. Tumour growth inhibition with palustran was about 30%. Polysaccharide administration to BALB/c nu/nu mice was not accompanied by tumour growth inhibition. The data obtained suggest that inhibition of Crocker sarcoma growth in mice injected the above polysaccharides is mediated by stimulation of antitumour T-cell activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Sergeev", "ForeName": "A V", "Initials": "AV"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Revazova", "ForeName": "E S", "Initials": "ES"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Denisova", "ForeName": "S I", "Initials": "SI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kalatskaia", "ForeName": "O V", "Initials": "OV"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Rytenko", "ForeName": "A N", "Initials": "AN"}], "PublicationTypeList": ["Comparative Study", "Journal Article"], "VernacularTitle": "Immunomoduliruiushchaia i protivoopukholevaia aktivnost' polisakharidov rastitel'nogo proiskhozhdeniia."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Biull Eksp Biol Med", "NlmUniqueID": "0370627", "ISSNLinking": "0365-9615"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Polysaccharides"}, {"RegistryNumber": "101063-11-0", "NameOfSubstance": "palustran"}, {"RegistryNumber": "101063-27-8", "NameOfSubstance": "tagetan"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Cytotoxicity Tests, Immunologic"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["drug effects"], "DescriptorName": "L Cells"}, {"QualifierName": [], "DescriptorName": "Lymphocyte Culture Test, Mixed"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C3H"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Polysaccharides"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sarcoma 180"}, {"QualifierName": ["drug effects"], "DescriptorName": "T-Lymphocytes, Cytotoxic"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1985", "Month": "12", "Day": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1985", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2934103"]}}]}